Table 4.
Association between miRNA and clinical parameters in cancer patients.
| Cancer Type | Sample | Size (Cancer/Control) | Grade | T Stage | N Stage | TNM | Survival | Reference |
|---|---|---|---|---|---|---|---|---|
| Bladder | Tissues | 22/22 | ● | [81] | ||||
| Breast | Blood | 35/33 | ● | [82] | ||||
| Cervical | Tissue | 40/40 | ● | ● | [83] | |||
| Esophagus | Tissue | 30/30 | ● | [84] | ||||
| Gall bladder | Tissue | 40/8 | ● | [85] | ||||
| Gastric | Tissue | 289/0 | ● | [86] | ||||
| Gastric | Tissue | 60/60 | ● | ● | [87] | |||
| Glioblastoma | Blood | 117/0 | ● | [88] | ||||
| Liver | Tissues | 60/60 | ● | [89] | ||||
| Liver | Tissues | 150/150 | ● | ● | ● | ● | ● | [90] |
| Liver | Tissues | 10/10 | ● | [91] | ||||
| Larynx | Tissue | 188/0 | ● | ● | ● | ● | ● | [92] |
| Melanoma | Tissue | 83/83 | ● | ● | [93] | |||
| Ovarian | Tissue | 414/0 | ● | ● | [93] | |||
| Prostate | Tissue | 64/64 | ● | [94] | ||||
| Prostate | Blood | 64/55 | ● | [94] |
Dot indicate positive association.